Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 3, 2014, Pages 217-222

  Ronai, Zsolt ^a   Kovacs Nagy, Reka ^a   Szantai, Eszter ^a   Elek, Zsuzsanna ^a   Sasvari Szekely, Maria ^a   Faludi, Gabor ^a   Benkovits, Judit ^a   Rethelyi, Janos M ^a   Szekely, Anna ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Bipolar depression; Copy number variation; Glycogen synthase kinase 3 beta; GSK3B; Major depression; Structural variants

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ADULT; ARTICLE; BIPOLAR DEPRESSION; C3ORF15 GENE; CONTROLLED STUDY; COPY NUMBER VARIATION; EXON; FEMALE; GENE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; NR1I2 GENE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; ADOLESCENT; AGED; BIPOLAR DISORDER; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 84897480864     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32223     Document Type: Article

References (28)

1. Arason GJ, Kramer J, Blasko B, Kolka R, Thorbjornsdottir P, Einarsdottir K, Sigfusdottir A, Sigurdarson ST, Sigurdsson G, Ronai Z, et al. 2007. Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol 149: (1):132-138.
2. Blasko B, Kolka R, Thorbjornsdottir P, Sigurdarson ST, Sigurdsson G, Ronai Z, Sasvari-Szekely M, Bodvarsson S, Thorgeirsson G, Prohaszka Z, et al. 2008. Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction. Int Immunol 20(1):31-37.
3. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. 2004. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36(2):131-137.
4. Fanciulli M, Petretto E, Aitman TJ. 2010. Gene copy number variation and common human disease. Clin Genet 77(3):201-213.
5. Flomen RH, Collier DA, Osborne S, Munro J, Breen G, St Clair D, Makoff AJ. 2006. Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141B(6):571-575.
6. Gould TD, Zarate CA, Manji HK. 2004. Glycogen synthase kinase-3: A target for novel bipolar disorder treatments. J Clin Psychiatry 65(1):10-21.
7. Hur EM, Zhou FQ. 2010. GSK3 signalling in neural development. Nat Rev Neurosci 11(8):539-551.
8. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. 2004. Detection of large-scale variation in the human genome. Nat Genet 36(9):949-951.
9. Klein PS, Melton DA. 1996. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93(16):8455-8459.
10. Lachman HM. 2008. Copy variations in schizophrenia and bipolar disorder. Cytogenet Genome Res 123(1-4):27-35.
11. Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, Novak T, Papolos DF, Stopkova P. 2007. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 144B(3):259-265.
12. Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK, Tassa C, Berry EM, Soda T, Singh KK, et al. 2009. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 136(6):1017-1031.
13. McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y, Tsung EF, Clouser CR, Duncan C, Ichikawa JK, Lee CC, et al. 2009. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res 19(9):1527-1541.
14. Menashe I, Rosenberg PS, Chen BE. 2008. PGA: Power calculator for case-control genetic association analyses. BMC Genet 9:36.
15. Mills RE, Luttig CT, Larkins CE, Beauchamp A, Tsui C, Pittard WS, Devine SE. 2006. An initial map of insertion and deletion (INDEL) variation in the human genome. Genome Res 16(9):1182-1190.
16. Moon HJ, Yim SV, Lee WK, Jeon YW, Kim YH, Ko YJ, Lee KS, Lee KH, Han SI, Rha HK. 2006. Identification of DNA copy-number aberrations by array-comparative genomic hybridization in patients with schizophrenia. Biochem Biophys Res Commun 344(2):531-539.
17. O'Brien WT, Huang J, Buccafusca R, Garskof J, Valvezan AJ, Berry GT, Klein PS. 2011. Glycogen synthase kinase-3 is essential for beta-arrestin-2 complex formation and lithium-sensitive behaviors in mice. J Clin Invest 121(9):3756-3762.
18. Saus E, Soria V, Escaramis G, Crespo JM, Valero J, Gutierrez-Zotes A, Martorell L, Vilella E, Menchon JM, Estivill X, et al. 2010. A haplotype of glycogen synthase kinase 3beta is associated with early onset of unipolar major depression. Genes Brain Behav 9(7):799-807.
19. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi MY, et al. 2004. Large-scale copy number polymorphism in the human genome. Science 305(5683):525-528.
20. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ. 1990. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336(8706):13-16.
21. Stankiewicz P, Lupski JR. 2010. Structural variation in the human genome and its role in disease. Annu Rev Med 61:437-455.
22. Suh JH, Choi E, Cha MJ, Song BW, Ham O, Lee SY, Yoon C, Lee CY, Park JH, Lee SH, et al. 2012. Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3beta protein expression. Biochem Biophys Res Commun 423(2):404-410.
23. Szantai E, Elek Z, Guttman A, Sasvari-Szekely M. 2009. Candidate gene copy number analysis by PCR and multicapillary electrophoresis. Electrophoresis 30(7):1098-1101.
24. Szilagyi A, Blasko B, Szilassy D, Fust G, Sasvari-Szekely M, Ronai Z. 2006. Real-time PCR quantification of human complement C4A and C4B genes. BMC Genet 7:1.
25. Szczepankiewicz A, Skibinska M, Hauser J, Slopien A, Leszczynska-Rodziewicz A, Kapelski P, Dmitrzak-Weglarz M, Czerski PM, Rybakowski JK. 2006. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 53(1):51-56.
26. Tiszlavicz Z, Szabolcs A, Takacs T, Farkas G, Kovacs-Nagy R, Szantai E, Sasvari-Szekely M, Mandi Y. 2010. Polymorphisms of beta defensins are associated with the risk of severe acute pancreatitis. Pancreatology 10(4):483-490.
27. Van Wauwe J, Haefner B. 2003. Glycogen synthase kinase-3 as drug target: From wallflower to center of attention. Drug News Perspect 16(9):557-565.
28. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A, He W, Chen YJ, Makhijani V, Roth GT, et al. 2008. The complete genome of an individual by massively parallel DNA sequencing. Nature 452(7189):872-876.